Evidence map›Paper›PMID 29858171›Full record

ArticleAnnals of the rheumatic diseases2019

Comment on: 'Aberrant tRNA processing causes an autoinflammatory syndrome responsive to TNF inhibitors' by Giannelou

Marie-Louise Frémond, Isabelle Melki, Sven Kracker, Vincent Bondet, Darragh Duffy, Gillian I Rice, Yanick J Crow, Brigitte Bader-Meunier

Open access · bronzeAbstract readLetterComment
PubMed Publisher
In one paragraph

Article in Annals of the rheumatic diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Marie-Louise FrémondParis Descartes University, Sorbonne-Paris-Cité, Imagine Institute, Paris, France.
Isabelle MelkiParis Descartes University, Sorbonne-Paris-Cité, Imagine Institute, Paris, France.
Sven KrackerParis Descartes University, Sorbonne-Paris-Cité, Imagine Institute, Paris, France.
Vincent BondetImmunobiology of Dendritic Cells, Institut Pasteur, Paris, France.
Darragh DuffyImmunobiology of Dendritic Cells, Institut Pasteur, Paris, France.
Gillian I RiceDivision of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Yanick J Crow *Paris Descartes University, Sorbonne-Paris-Cité, Imagine Institute, Paris, France.
Brigitte Bader-Meunier *Paris Descartes University, Sorbonne-Paris-Cité, Imagine Institute, Paris, France.
Hôpital Necker-Enfants Malades · FRInserm · FRAssistance Publique – Hôpitaux de Paris · FRInstitut des Maladies Génétiques Imagine · FRInstitut Pasteur · FRUniversity of Manchester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Interferon Type ITumor Necrosis Factor InhibitorsGene ExpressionMutationRNA, TransferInterferon Type IRNA, TransferTumor Necrosis Factor Inhibitorsdisease activityrehabilitationtreatment

Identifiers

PMID29858171
OpenAlexW2807387575

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.